During the corresponding time, Zoetis Inc recorded a revenue increase by 0.33 % year on year, sequentially revenue grew by 9.11 %. While revenue at the Zoetis Inc 's corporate clients
Zoetis Inc's Comment on Sales, Marketing and Customers
Zoetis Inc. operates in the global animal health market, providing products for eight core species: dogs, cats, horses, cattle, swine, poultry, fish, and sheep. Its customer base includes veterinarians, pet owners, and livestock producers worldwide. The company offers products in seven major categories: parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and animal health diagnostics. Market segmentation reflects regional variations in customer needs influenced by economic and cultural factors. Zoetis Inc. is associated with Pfizer Inc. in its filings.
Zoetis: Leading the Pack in Animal Health and Diversity ExcellenceZoetis Inc. (NYSE: ZTS), a global leader in animal health, has garnered a prestigious accolade by being named to Fair360 s Top 50 Companies for Diversity, Equity, and Inclusion (DEandI) for the first time. This recognition emphasizes the company s unwavering dedication and continuous strides in promoting a diverse and inclusive workplace, marking a significant milestone for the organization. A Standout in Animal Health and DEandI What sets Zoetis apart from its peers is that it is the only animal health company to be included in this year s Top 50 rankings by Fair360 (formerly known as DiversityInc). This unique distinction is a testament to ...
In a recent announcement, Zoetis Inc., a leading global animal health company, shared its financial results for the first quarter of 2024. The company celebrated a remarkable revenue growth of 10% compared to the same period in 2023, showcasing its strong market performance and strategic initiatives. This article aims to examine the key facts and assess their implications on Zoetis Inc. s overall business trajectory within the animal health industry.Revenue Growth and Operational Performance:Zoetis Inc. recorded an impressive revenue of $2.2 billion during the first quarter of 2024. This marked a substantial 12% increase on an operational basis compared to the same period in 2023. The company s unwavering co...
Zoetis Inc’s Comment on Sales, Marketing and Customers
Zoetis Inc. operates in the global animal health market, providing products for eight core species: dogs, cats, horses, cattle, swine, poultry, fish, and sheep. Its customer base includes veterinarians, pet owners, and livestock producers worldwide. The company offers products in seven major categories: parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and animal health diagnostics. Market segmentation reflects regional variations in customer needs influenced by economic and cultural factors. Zoetis Inc. is associated with Pfizer Inc. in its filings.
Sources:
Zoetis Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Zoetis Inc’s corporate clients.
For your research, we’ve provided 9 tables on Zoetis Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
95.46 %